Tinkeso Therapeutics

Venture Round
tinkeso.com Biotech & Healthcare
Total Funding Undisclosed
Latest Round Undisclosed Venture Round
Last Announced Undisclosed
Investors 1 Backer
Decision Makers Profile Active

About Tinkeso Therapeutics

Is to address the patient unmet needs with our novel off-the-shelf, allogeneic Natural Killer T (NKT) cell therapies for the treatment of cancers and other immune-mediated disorders.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Venture Round
Global Headquarters Undisclosed
Tracked Since Oct 11, 2026

Web & Domain Identity

Official Website tinkeso.com
Domain Registered Date Apr 26, 2024

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Milestone

    Website domain registered

    tinkeso.com

Investors & Backers

1
IndieBio

Funding History

Venture Round · Undisclosed

Backers: IndieBio

Undisclosed Source

Founders & Leadership

2

Emmie Fan

Co-Founder/CEO

Work email & phone locked Unlock →

Xianzheng (Jerry) Zhou

Founder/CSO, Chairman of the Board

Work email & phone locked Unlock →

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts